(Updated - June 9, 2026 6:26 AM EDT)

Barclays analyst Luke Sergott upgraded West Pharmaceutical (NYSE: WST) from Equalweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE